Further, we successfully obtained the CD4+ TCRs recognizing B65 and confirmed that the constructed B65 TCR-T could display strong functional activity against SARS-CoV-2 S. Our findings provide vital information for understanding the cellular immunity against SARS-CoV-2 and for the development of effective strategies for COVID-19 treatment. Here, CD4 is linked to COVID-19.